Setting a foundation in 3D bioprinting across the world to bring about a new age in tissue and organ engineering.
Allevi makes bioprinters that are powerful, accessible, and easy-to-use.
Allevi combines powers printers with easy to use protocols and versatile design ability.
Allevi ZeroG will revolutionize how biology is studied in space with the goal to achieve complex structures with low viscosity biomaterials not possible on Earth
The 3D Bioprinting Market is worth ~$1.2B and isforecasted to reach $4.1B by 2026, growing at a CAGR of ~20%. Allevi has shown considerable traction in the Medical Research market, and with the development of the company’s pharma kits, Allevi hopes to penetrate the highly lucrative pharmaceutical industry